MELANOCYTIC HYPERPLASIA

MELANOCYTIC HYPERPLASIA was reported 32 times

MELANOCYTIC HYPERPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Dihydrofolate Reductase Inhibitor Antimalarial [EPC] 1 0.0008
1 Sulfone [EPC] 1 0.0001
2 Sphingosine 1-phosphate Receptor Modulator [EPC] 1 0.0001
3 Provitamin D2 Compound [EPC] 2 0.0001
4 5-alpha Reductase Inhibitor [EPC] 6 0.0001
5 Cholinesterase Inhibitor [EPC] 1 0.0001
6 Azole Antifungal [EPC] 4 0.0000
7 Histamine-1 Receptor Antagonist [EPC] 2 0.0000
8 Cardiac Glycoside [EPC] 1 0.0000
9 Purine Antimetabolite [EPC] 1 0.0000
10 Dihydropyridine Calcium Channel Blocker [EPC] 3 0.0000
11 Aromatase Inhibitor [EPC] 1 0.0000
12 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
13 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
14 alpha-Adrenergic Blocker [EPC] 1 0.0000
15 Calcium [EPC] 1 0.0000
16 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
17 Estrogen [EPC] 1 0.0000
18 Platelet Aggregation Inhibitor [EPC] 3 0.0000
19 RANK Ligand Inhibitor [EPC] 1 0.0000
20 Expectorant [EPC] 1 0.0000
21 Thiazide Diuretic [EPC] 1 0.0000
22 Anti-epileptic Agent [EPC] 1 0.0000
23 Atypical Antipsychotic [EPC] 2 0.0000
24 Opioid Agonist [EPC] 1 0.0000
25 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
26 Kinase Inhibitor [EPC] 2 0.0000
27 Vitamin D [EPC] 1 0.0000
28 beta-Adrenergic Blocker [EPC] 1 0.0000
29 Vitamin B12 [EPC] 1 0.0000
30 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
31 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
32 Vitamin C [EPC] 1 0.0000
33 Corticosteroid [EPC] 3 0.0000
34 Loop Diuretic [EPC] 1 0.0000
35 Tumor Necrosis Factor Blocker [EPC] 1 0.0000